Portfolio (Quarterly)
Guide ↗
Kalehua Capital Management LLC
· CIK 0002106181| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BOXX | Alpha Architect 1-3 Month Box Etf | — | 230,787.0 | $26.6M | 26.27% | NEW | — | $115.10 | +1.5% |
| 2 | XFOR | X4 Pharmaceuticals Inc | Healthcare | 3,722,840.0 | $14.9M | 14.73% | NEW | — | $4.00 | -5.8% |
| 3 | SION | Sionna Therapeutics Inc | Healthcare | 197,072.0 | $8.1M | 8.02% | NEW | — | $41.14 | -4.0% |
| 4 | RLAY | Relay Therapeutics Inc | Healthcare | 901,457.0 | $7.6M | 7.54% | NEW | — | $8.46 | +53.9% |
| 5 | CMPS | Compass Pathways Plc | Healthcare | 819,692.0 | $5.7M | 5.59% | NEW | — | $6.90 | +68.0% |
| 6 | PHVS | Pharvaris NV | Healthcare | 198,772.0 | $5.5M | 5.46% | NEW | — | $27.75 | +6.1% |
| 7 | SEPN | Septerna Inc | Healthcare | 194,544.0 | $5.4M | 5.37% | NEW | — | $27.88 | +0.5% |
| 8 | ORKA | Oruka Therapeutics Inc | Healthcare | 118,524.0 | $3.6M | 3.55% | NEW | — | $30.31 | +93.6% |
| 9 | — | Inhibikase Therapeutics Inc | — | 1,750,000.0 | $3.6M | 3.55% | NEW | — | $2.05 | — |
| 10 | ALLO | Allogene Therapeutics Inc | Healthcare | 2,546,129.0 | $3.5M | 3.45% | NEW | — | $1.37 | +43.1% |
| 11 | LONA | LeonaBio Inc | Healthcare | 393,701.0 | $3.0M | 2.95% | NEW | — | $7.57 | +33.0% |
| 12 | MLTX | MoonLake Immunotherapeutics | Healthcare | 175,734.0 | $2.3M | 2.29% | NEW | — | $13.18 | +40.1% |
| 13 | ORIC | Oric Pharmaceuticals Inc | Healthcare | 267,059.0 | $2.2M | 2.16% | NEW | — | $8.18 | +3.4% |
| 14 | VRCA | Verrica Pharmaceuticals Inc | Healthcare | 235,779.0 | $2.0M | 1.94% | NEW | — | $8.31 | -27.6% |
| 15 | TYRA | Tyra Biosciences Inc | Healthcare | 74,465.0 | $2.0M | 1.94% | NEW | — | $26.29 | +27.0% |
| 16 | — | Surrozen Inc | — | 385,178.0 | $1.9M | 1.87% | NEW | — | $4.90 | — |
| 17 | TNYA | Tenaya Therapeutics Inc | Healthcare | 2,000,000.0 | $1.4M | 1.41% | NEW | — | $0.71 | +13.6% |
| 18 | KLRS | Kalaris Therapeutics Inc | Healthcare | 139,901.0 | $1.2M | 1.17% | NEW | — | $8.44 | -39.3% |
| 19 | DMAC | Diamedica Therapeutics Inc | Healthcare | 95,359.0 | $759K | 0.75% | NEW | — | $7.96 | -27.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%